Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study

被引：0

作者：

Hauser, Robert ^{[1
]}

Barkay, Hadas ^{[2
]}

Fernandez, Hubert ^{[3
]}

Factor, Stewart ^{[4
]}

Jimenez-Shahed, Joohi ^{[5
]}

Gross, Nicholas ^{[6
]}

Savola, Juha-Matti ^{[7
]}

Anderson, Karen E. ^{[8
]}

机构：

[1] Univ S Florida, Parkinsons Dis & Movement Disorders Ctr, Tampa, FL USA

[2] Teva Pharmaceut, Netanya, Israel

[3] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA

[4] Emory Univ, Atlanta, GA 30322 USA

[5] Baylor Coll Med, Houston, TX 77030 USA

[6] Teva Pharmaceut, Frazer, PA USA

[7] Teva Pharmaceut Int, Basel, Switzerland

[8] Georgetown Univ, Washington, DC USA

来源：

NEUROLOGY | 2019年 / 92卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S4.009

引用

页数：4

共 50 条

[21] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
[22] Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
Yokota, Shumpei
Imagawa, Tomoyuki
Mori, Masaaki
Miyamae, Takako
Takei, Syuji
Iwata, Naomi
Umebayashi, Hiroaki
Murata, Takuji
Miyoshi, Mari
Tomiita, Minako
Nishimoto, Norihiro
Kishimoto, Tadamitsu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 627 - 628
[23] Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study
Haab, Francois
Corcos, Jacques
Siami, Paul
Glavind, Karin
Dwyer, Peter
Steel, Michael
Kawakami, Fernando
Lheritier, Karine
Steers, William D.
[J]. BJU INTERNATIONAL, 2006, 98 (05) : 1025 - 1032
[24] Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-Label Study
Frank, Samuel
Testa, Claudia M.
Stamler, David
Kayson, Elise
Oakes, David
Vaughan, Christina
Goldstein, Jody
Whaley, Jacquelyn
Davis, Matthew D.
Gordon, Mark Forrest
Savolay, Juha-Matti
[J]. NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 27 - 28
[25] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial
Ashina, Messoud
Roos, Caroline
Li, Lily Qian
Komori, Mika
Ayer, David
Ruff, Dustin
Krege, John Henry
[J]. CEPHALALGIA, 2023, 43 (04)
[26] Deutetrabenazine Reduces Involuntary Movements in Patients Most Severely Impacted by Tardive Dyskinesia in a 3-year Open-Label Extension Trial
Bona, J.
Barkay, H.
Wilhelm, A.
Chaijale, N.
Gordon, M.
[J]. MOVEMENT DISORDERS, 2020, 35 : S31 - S32
[27] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
Chiorean, Michael
Vermeire, Severine
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Cabell, Chris H.
Naik, Snehal U.
Klassen, Preston
Sandborn, William J.
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
[28] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
Vermeire, Severine
Chiorean, Michael
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Klassen, Preston
Naik, Snehal U.
Cabell, Christopher H.
Sandborn, William J.
[J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
[29] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
Grossman, J
Smith, LJ
Wilson, AM
Thyrum, PT
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
[30] LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
Trachtman, Howard
Srivastava, Tarak
Tesar, Vladimir
Campbell, Kirk N.
Rheault, Michelle N.
Komers, Radko
Murphy, Edward
Prasad, Andy
Gesualdo, Loreto
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S99 - S99

← 1 2 3 4 5 →